Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Laruelle

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
Synapse (New York, N.Y.)|March 2, 1999
Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humansL S Kegeles, Y Zea-Ponce, A Abi-Dargham, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 29, 2001
Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatumO Mawlawi, D Martinez, M Slifstein, et al.
Molecular Psychiatry|March 5, 2008
COMT genotype predicts cortical-limbic D1 receptor availability measured with [11C]NNC112 and PETM Slifstein, B Kolachana, E H Simpson, et al.
Biological Psychiatry|October 18, 2000
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophreniaL S Kegeles, A Abi-Dargham, Y Zea-Ponce, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 25, 2000
Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functionsR V Parsey, M Slifstein, D R Hwang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 18, 1999
No evidence of altered in vivo benzodiazepine receptor binding in schizophreniaA Abi-Dargham, M Laruelle, J Krystal, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1993
Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson diseaseR B Innis, J P Seibyl, B E Scanley, et al.
Neuroimage|August 13, 2013
Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHDY-S Ding, M Naganawa, J-D Gallezot, et al.
Biological Psychiatry|September 7, 2001
Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depressionR V Parsey, M A Oquendo, Y Zea-Ponce, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1994
SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigmsA Abi-Dargham, M Laruelle, J Seibyl, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
Synapse (New York, N.Y.)|March 2, 1999
Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humansL S Kegeles, Y Zea-Ponce, A Abi-Dargham, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 29, 2001
Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatumO Mawlawi, D Martinez, M Slifstein, et al.
Molecular Psychiatry|March 5, 2008
COMT genotype predicts cortical-limbic D1 receptor availability measured with [11C]NNC112 and PETM Slifstein, B Kolachana, E H Simpson, et al.
Biological Psychiatry|October 18, 2000
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophreniaL S Kegeles, A Abi-Dargham, Y Zea-Ponce, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 25, 2000
Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functionsR V Parsey, M Slifstein, D R Hwang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 18, 1999
No evidence of altered in vivo benzodiazepine receptor binding in schizophreniaA Abi-Dargham, M Laruelle, J Krystal, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1993
Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson diseaseR B Innis, J P Seibyl, B E Scanley, et al.
Neuroimage|August 13, 2013
Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHDY-S Ding, M Naganawa, J-D Gallezot, et al.
Biological Psychiatry|September 7, 2001
Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depressionR V Parsey, M A Oquendo, Y Zea-Ponce, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1994
SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigmsA Abi-Dargham, M Laruelle, J Seibyl, et al.
Pageof 11